Metraipolis › archive › dc_ca8634f60d06
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a… — Europe PMC PMID:42395119
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42395119
- DOI
- 10.1002/ags3.70202
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T14:03:09.572Z
- SHA-256 of the archived text
543d7bd59bad1e73060420f7903716913e4c991358283c10bb6190ca7207d8c6- Stable URL of this page
https://metraipolis.com/documento/dc_ca8634f60d06
How to cite
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a… — Europe PMC PMID:42395119 — Europe PMC (en), https://europepmc.org/article/MED/42395119 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca8634f60d06 (Metraipolis archive dc_ca8634f60d06, sha256 543d7bd59bad1e73060420f7903716913e4c991358283c10bb6190ca7207d8c6)
BibTeX
@misc{dcca8634f60d06,
title = {Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a… — Europe PMC PMID:42395119},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42395119},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca8634f60d06; sha256 543d7bd59bad1e73060420f7903716913e4c991358283c10bb6190ca7207d8c6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42395119. Agents can read the archived copy with the MCP tool read_document.